Retinoblastoma News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

UNBS5162 inhibits proliferation of human retinoblastoma cells by promoting cell apoptosis - Dove Medical Press



UNBS5162 inhibits proliferation of human retinoblastoma cells by promoting cell apoptosis 
Dove Medical Press
Abstract: Human retinoblastomas are malignant intraocular tumors and have a high incidence in children. Chemotherapy combined with local therapy is the principal means of retinoblastoma treatment, the application of which has saved the eye of many ...

 


US retinoblastoma guidelines released - AOP



AOP
 
US retinoblastoma guidelines released 
AOP
The guidelines include ophthalmic screening for all children at risk of retinoblastoma above the population risk. Genetic counselling and testing for children with a family history of the disease is also suggested. It is recommended that those who are ...

 


Parental exposure to hazardous agents tied to eye tumors in offspring - Reuters



Parental exposure to hazardous agents tied to eye tumors in offspring 
Reuters
By Mary Gillis(Reuters Health) - Parents' exposure to chemicals at work might be linked to eye cancer in their children, a report from some of the wo.

and more » 


Thetford toddler's thanks to West Suffolk Hospital nurses after ... - Norfolk Eastern Daily Press



Norfolk Eastern Daily Press
 
Thetford toddler's thanks to West Suffolk Hospital nurses after ... 
Norfolk Eastern Daily Press
Lucy and Lavinia Crosbie share gifts with West Suffolk Hospital Rainbow Ward patient Clara. The pair donated items and visited the ward to say thank you after ...
Generous Lavinia donates toys and gifts to children's ward at the ... East Anglian Daily Times

all 2 news articles » 


Retinoblastoma Treatment Market to Develop Rapidly by 2027 ... - Find Market Research By Abhishek Budholiya (press release) (blog)



Retinoblastoma Treatment Market to Develop Rapidly by 2027 ... 
Find Market Research By Abhishek Budholiya (press release) (blog)
Cancer is the leading cause of death worldwide with 8.2 million cancer related deaths in 2012 estimated by World Health Organization (WHO). Retinoblastoma ...

and more » 


Retinoblastoma Pharmaceutical and Healthcare Pipeline Review ... - Medgadget (blog)



Retinoblastoma Pharmaceutical and Healthcare Pipeline Review ... 
Medgadget (blog)
Summary Retinoblastoma is an eye cancer that begins in the retina. Symptoms include white color in the center circle of the eye (pupil), eye redness, visio.

and more » 


USC Roski Eye Institute Experts Present Breakthrough Research at AAO 2017 - Newswise (press release)



USC Roski Eye Institute Experts Present Breakthrough Research at AAO 2017 
Newswise (press release)
Unlike most cancers that are diagnosed using a biopsy, retinoblastoma tumors cannot be directly biopsied. On Nov. 12, Jesse Berry, MD, ocular oncologist at the Vision Center at Children's Hospital Los Angeles (CHLA) and Keck School of Medicine of USC ...
Leaders and Innovators in Medical and Surgical Eye Care Honored ... Markets Insider

all 3 news articles » 


St. Jude Children's Hospital patients surprised by Snug from 'Sprout ... - Today.com



Today.com
 
St. Jude Children's Hospital patients surprised by Snug from 'Sprout ... 
Today.com
The kids put their worries aside for a fun day with Snug from "Sprout House" as part of TODAY's "Thanks and Giving" series.

and more » 


Retinoblastoma Drugs Market Growth Opportunities, Analysis and ... - MilTech



Retinoblastoma Drugs Market Growth Opportunities, Analysis and ... 
MilTech
Retinoblastoma Drugs Market report focuses on the major drivers and restraints for the key players. It also provides granular analysis of the market share,

and more » 


Retinoblastoma Pipeline Analysis and Review H2 2017 - E News Access (press release)



Retinoblastoma Pipeline Analysis and Review H2 2017 
E News Access (press release)
Retinoblastoma Pipeline and Therapeutics Development H1 2017 provides comprehensive information on the therapeutics under development for ...

and more »